7-Methylpyrazolo[1,5-a][1,3,5]triazin-4(3H)-one, 95.0%, 250mg

(2S,6S)-2,6-Dimethylmorpholine, 98%, 1g

1-(Propan-2-yl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine hydrochloride, 1g

1-(4-Methylbenzoyl)-1H-1,2,3-benzotriazole, 100mg

Methyl6-(tert-Butyl)thieno[3,2-d]pyrimidine-4-carboxylate, 97%, 100mg

tert-Butyl 4-((trimethylsilyl)oxy)-5,6-dihydropyridine-1(2H)-carboxylate, 95.0%, 25g

3-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 95+%, 250mg

N-Ethyl-2-methylallylamine, 97%, 1g

3-(3-fluorophenyl)prop-2-ynoic acid, 95.0%, 1g

1-(3-Aminopropyl)imidazole, 98.0%, 100g

Fluoxetine hydrochloride, 98.0%, 25g

2-(3-Fluoro-5-methylphenyl)acetic acid, 95.0%, 10g

Etalon de viscosité N350, ROTI®Calipure, 980 cSt (20 °C), 500 ml, emballage verre